Associations Between Diabetes and Quality of Life Among Breast Cancer Survivors

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jun 23

PMID 27333326

Citations 19

Authors

Zheng Tang

Jiwei Wang

Hao Zhang

Li Sun

Furong Tang

Qinglong Deng

Jinming Yu

Affiliations

Soon will be listed here.

Abstract

Objective: We aimed to investigate the associations between diabetes and quality of life (QOL) among breast cancer survivors.

Methods: A cross-sectional survey was conducted at 34 Cancer Recovery Clubs across China from May 2014 to January 2015. Quality of life was measured by the Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and the Quality of Life Questionnaire-Breast Cancer Module 23 (QLQ-BR23, simplified Chinese version). Information on social-demography, diagnosis and treatment of tumors, and diabetes mellitus were collected by self-reported questionnaires. Univariate analyses of covariance (ANCOVA) was performed to assess the difference in QOL between patients with or without diabetes mellitus, and multiple linear regression models were used to examine the associations after controlling for confounders.

Results: Diabetes, both of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) significantly reduced QOL. This effect of diabetes on QOL is independent of tumor size, regional lymph node metastasis, distant metastasis and tumor stage index (TNM). After adjusting for different social-demography, diagnosis and treatment of the tumor, the tumor's stage and other chronic comorbidities, breast cancer survivors with diabetes got significantly lower scores in functional dimensions (including physical, role, emotional and social functionings measured by EORTC QLQ-C30; body image (BRBI) and future perspective (BRFU) measured by QLQ-BR23, as well as economic difficulties than those without diabetes (Padjusted<0.05). Diabetic patients also obtained higher scores in symptom dimensions, including fatigue, nausea and vomiting, pain, dyspnoea, insomnia, constipation and diarrhoea measured by EORTC QLQ-C30; side effects, breast symptoms and upset by hair loss measured by QLQ-BR23 (Padjusted<0.05). Compared to patients with T1DM, those with T2DM are likely to suffer more by loss of functioning.

Conclusions: Diabetes was associated with the decreased QOL for breast cancer survivors.

Citing Articles

The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study.

Ose D, Adediran E, Mark B, Ocier K, Dunson Jr W, Turner C Cancer Med. 2024; 13(20):e70246.

PMID: 39445809 PMC: 11500209. DOI: 10.1002/cam4.70246.

Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk.

Abu Irsheed G, Martyn-Nemeth P, Baron K, Reutrakul S J Clin Endocrinol Metab. 2024; 109(12):3011-3026.

PMID: 39106222 PMC: 11570394. DOI: 10.1210/clinem/dgae539.

Understanding the Quality of Life Among Patients With Cancer in Saudi Arabia: Insights From a Cross-Sectional Study.

Aljawadi M, Alkhudair N, Alrasheed M, Alsuhaibani A, Alotaibi B, Almuqbil M Cancer Control. 2024; 31:10732748241263013.

PMID: 38870396 PMC: 11179550. DOI: 10.1177/10732748241263013.

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer.

Sarkar M, Mia M, Al Amin M, Hossain M, Islam M Heliyon. 2023; 9(5):e16151.

PMID: 37234659 PMC: 10205526. DOI: 10.1016/j.heliyon.2023.e16151.

Analysis of the Incidence of Type 2 Diabetes, Requirement of Insulin Treatment, and Diabetes-Related Complications among Patients with Cancer.

Lee S, Kim C, Yu H, Kim D Cancers (Basel). 2023; 15(4).

PMID: 36831436 PMC: 9953816. DOI: 10.3390/cancers15041094.

References

Peairs K, Barone B, Snyder C, Yeh H, Stein K, Derr R . Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2010; 29(1):40-6. PMC: 3055858. DOI: 10.1200/JCO.2009.27.3011. View

Giovannucci E, Harlan D, Archer M, Bergenstal R, Gapstur S, Habel L . Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010; 60(4):207-21. DOI: 10.3322/caac.20078. View

Chen W, Shao Y, Shau W, Lin Z, Lu Y, Chen H . The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist. 2012; 17(4):485-91. PMC: 3336825. DOI: 10.1634/theoncologist.2011-0412. View

Romero-Figueroa M, Garduno-Garcia J, Duarte-Mote J, Matute-Gonzalez G, Gomez-Villanueva A, De la Cruz-Vargas J . Insulin and leptin levels in obese patients with and without breast cancer. Clin Breast Cancer. 2013; 13(6):482-5. DOI: 10.1016/j.clbc.2013.08.001. View

Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D . Quality of life after breast cancer diagnosis and survival. J Clin Oncol. 2010; 29(4):406-12. PMC: 3058286. DOI: 10.1200/JCO.2010.30.6951. View

Bowker S, Majumdar S, Veugelers P, Johnson J . Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 2006; 29(2):254-8. DOI: 10.2337/diacare.29.02.06.dc05-1558. View

Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J . Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362(12):1090-101. DOI: 10.1056/NEJMoa0908292. View

Tseng C, Chong C, Tai T . Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia. 2008; 52(2):240-6. DOI: 10.1007/s00125-008-1204-8. View

Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B . Diabetes mellitus and breast cancer. Lancet Oncol. 2005; 6(2):103-11. DOI: 10.1016/S1470-2045(05)01736-5. View

10.

Larsson S, Mantzoros C, Wolk A . Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007; 121(4):856-62. DOI: 10.1002/ijc.22717. View

11.

Erickson K, Patterson R, Flatt S, Natarajan L, Parker B, Heath D . Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol. 2010; 29(1):54-60. PMC: 3055860. DOI: 10.1200/JCO.2010.29.3183. View

12.

Luo J, Hendryx M, Virnig B, Wen S, Chlebowski R, Chen C . Pre-existing diabetes and breast cancer prognosis among elderly women. Br J Cancer. 2015; 113(5):827-32. PMC: 4559825. DOI: 10.1038/bjc.2015.249. View

13.

Joung K, Jeong J, Ku B . The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms. Biomed Res Int. 2015; 2015:920618. PMC: 4383430. DOI: 10.1155/2015/920618. View

14.

Krajcik R, Borofsky N, Massardo S, Orentreich N . Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev. 2002; 11(12):1566-73. View

15.

Hardefeldt P, Edirimanne S, Eslick G . Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer. 2012; 19(6):793-803. DOI: 10.1530/ERC-12-0242. View

16.

Hsieh M, Lee T, Cheng S, Tu S, Yen M, Tseng C . The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res. 2012; 2012:413782. PMC: 3374948. DOI: 10.1155/2012/413782. View

17.

Currie C, Poole C, Gale E . The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009; 52(9):1766-77. DOI: 10.1007/s00125-009-1440-6. View

18.

Xu H, Chen K, Jia X, Tian Y, Dai Y, Li D . Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis. Oncologist. 2015; 20(11):1236-44. PMC: 4718443. DOI: 10.1634/theoncologist.2015-0096. View

19.

Hernandez A, Guarnizo M, Miranda Y, Pasupuleti V, Deshpande A, Paico S . Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis. PLoS One. 2014; 9(6):e99317. PMC: 4049776. DOI: 10.1371/journal.pone.0099317. View

20.

Bao P, Zhao Z, Gao Y, Zheng Y, Zhang B, Cai H . Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women. PLoS One. 2015; 10(2):e0117419. PMC: 4332504. DOI: 10.1371/journal.pone.0117419. View